Market research
PME.AU Pro Medicus Limited
AU AUD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 17B
- P/E ratio
- 64.96
- Analyst target
- 202.4713
- Dividend yield
- 0.4%
- Beta
- 0.58
Profile
Company facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Health Information Services
- ISIN
- AU000000PME8
- Market cap
- 17B
- P/E ratio
- 64.96
- Analyst target
- 202.4713
- Dividend yield
- 0.4%
- Beta
- 0.58
About
About Pro Medicus Limited
Pro Medicus Limited, a healthcare informatics company, provides medical imaging software and services to hospitals, imaging centers, and health care groups in Australia, Europe, and North America. The company offers Visage RIS, an enterprise-class radiology information system for patient registration, billing, scheduling, typing, HL7 integration, financial reporting, picture archive and communication system (PACS) integration, digital dictation, and voice recognition integration; and Visage RIS/PACS, a solution for imaging needs of organizations. It also provides Visage 7 Enterprise Imaging Platform, a healthcare imaging software for radiologists, physicians, and clinicians for access and visualization capability comprising rapidly viewing 2-D, 3-D, and 4-D medical images, as well as PACS, digital imaging software, training, installation, and professional services and support products; and Visage Ease, a native mobile application for access to medical imaging results stored on a Visage 7 server from iOS devices, including iPad, iPhone, and iTouch. In addition, the company offers Visage Ease Pro for interpreting diagnostic imaging studies; and Promedicus.net, an e-health offering. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the PME.AU discussion.
5 years, 5 months ago
Pro Medicus Limited is currently in a long term uptrend where the price is trading 41.4% above its 200 day moving average.
From a valuation standpoint, the stock is 70.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 77.1.
Pro Medicus Limited's total revenue rose by 7.8% to $32M since the same quarter in the previous year.
Its net income has increased by 12.4% to $14M since the same quarter in the previous year.
Finally, its free cash flow grew by 89.4% to $8M since the same quarter in the previous year.
Based on the above factors, Pro Medicus Limited gets an overall score of 5/5.